Akebia Therapeutics
AKBA
AKBA
96 hedge funds and large institutions have $20.2M invested in Akebia Therapeutics in 2022 Q2 according to their latest regulatory filings, with 24 funds opening new positions, 17 increasing their positions, 34 reducing their positions, and 49 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding in top 10
Funds holding in top 10: →
less ownership
Funds ownership: →
less funds holding
Funds holding: →
50% less repeat investments, than reductions
Existing positions increased: 17 | Existing positions reduced: 34
51% less first-time investments, than exits
New positions opened: 24 | Existing positions closed: 49
65% less capital invested
Capital invested by funds: $58.3M → $20.2M (-$38.1M)
Holders
96
Holding in Top 10
1
Calls
$212K
Puts
$65K
Top Buyers
| 1 | +$2.59M | |
| 2 | +$961K | |
| 3 | +$655K | |
| 4 |
HF
HRT Financial
New York
|
+$380K |
| 5 |
E
Ergoteles
New York
|
+$300K |
Top Sellers
| 1 | -$3.86M | |
| 2 | -$3.39M | |
| 3 | -$1.77M | |
| 4 |
Dimensional Fund Advisors
Austin,
Texas
|
-$664K |
| 5 |
Geode Capital Management
Boston,
Massachusetts
|
-$542K |